loading
전일 마감가:
$33.12
열려 있는:
$32.7
하루 거래량:
42,865
Relative Volume:
0.68
시가총액:
$225.69M
수익:
-
순이익/손실:
$-4.98M
주가수익비율:
-24.32
EPS:
-1.3177
순현금흐름:
$-3.85M
1주 성능:
-12.22%
1개월 성능:
-0.59%
6개월 성능:
+2,662%
1년 성능:
+2,365%
1일 변동 폭
Value
$30.00
$33.65
1주일 범위
Value
$30.00
$38.33
52주 변동 폭
Value
$0.93
$79.02

Bright Minds Biosciences Inc Stock (DRUG) Company Profile

Name
명칭
Bright Minds Biosciences Inc
Name
전화
-
Name
주소
-
Name
직원
0
Name
트위터
Name
다음 수익 날짜
Name
최신 SEC 제출 서류
Name
DRUG's Discussions on Twitter

DRUG을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
DRUG
Bright Minds Biosciences Inc
32.04 225.69M 0 -4.98M -3.85M -1.3177
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
474.62 121.88B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
573.45 62.69B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
555.11 33.86B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
235.74 30.51B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
238.51 25.69B 3.81B -644.79M -669.77M -6.24

Bright Minds Biosciences Inc Stock (DRUG) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-01-23 개시 Piper Sandler Overweight
2025-01-10 개시 Cantor Fitzgerald Overweight
2025-01-10 개시 H.C. Wainwright Buy
2024-11-26 개시 Robert W. Baird Outperform

Bright Minds Biosciences Inc 주식(DRUG)의 최신 뉴스

pulisher
Apr 03, 2025

Reviewing Allarity Therapeutics (NASDAQ:ALLR) & Bright Minds Biosciences (NASDAQ:DRUG) - Defense World

Apr 03, 2025
pulisher
Apr 01, 2025

Discover the Top 5 Small-Cap Biotech Stocks in 2025 - Investing News Network

Apr 01, 2025
pulisher
Mar 21, 2025

Bright Minds Biosciences Inc. (NASDAQ:DRUG) Sees Significant Decrease in Short Interest - Defense World

Mar 21, 2025
pulisher
Mar 18, 2025

DRUG FY2025 EPS Estimate Decreased by Cantor Fitzgerald - The AM Reporter

Mar 18, 2025
pulisher
Mar 18, 2025

Cantor Fitzgerald Has Weak Forecast for DRUG FY2025 Earnings - Defense World

Mar 18, 2025
pulisher
Mar 15, 2025

Bright Minds Biosciences (NASDAQ:DRUG) Trading Down 0.8% – Here’s Why - Defense World

Mar 15, 2025
pulisher
Mar 09, 2025

Bright Minds Biosciences Independent Director Nils Bottler Sells 100% Of Holding - simplywall.st

Mar 09, 2025
pulisher
Mar 04, 2025

Bright Minds Biosciences Expands Scientific Advisory Board to Include Renowned Leaders in Epilepsy Research - GlobeNewswire

Mar 04, 2025
pulisher
Mar 04, 2025

Bright Minds Biosciences Strengthens Epilepsy Focus with New Advisory Board Members - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

Can These 5 Epilepsy Experts Accelerate Bright Minds' Breakthrough Drug Development? - StockTitan

Mar 04, 2025
pulisher
Feb 24, 2025

Bright Minds Biosciences to Participate at Three Healthcare Conferences in March - The Manila Times

Feb 24, 2025
pulisher
Feb 24, 2025

Can This CNS Drug Developer's Triple Conference Tour Spark Investor Interest? - StockTitan

Feb 24, 2025
pulisher
Feb 23, 2025

How the (DRUG) price action is used to our Advantage - news.stocktradersdaily.com

Feb 23, 2025
pulisher
Feb 22, 2025

HC Wainwright Issues Negative Estimate for DRUG Earnings - Defense World

Feb 22, 2025
pulisher
Feb 21, 2025

H.C. Wainwright maintains $85 target on Bright Minds stock By Investing.com - Investing.com Nigeria

Feb 21, 2025
pulisher
Feb 20, 2025

H.C. Wainwright maintains $85 target on Bright Minds stock - Investing.com India

Feb 20, 2025
pulisher
Feb 20, 2025

Bright Minds Biosciences (NASDAQ:DRUG) Given “Buy” Rating at HC Wainwright - Defense World

Feb 20, 2025
pulisher
Feb 19, 2025

Bright Minds Biosciences’ BMB-101: A Promising Contender in Serotonergic Epilepsy Treatment with Strong Market Potential - TipRanks

Feb 19, 2025
pulisher
Feb 14, 2025

Bright Minds Biosciences (NASDAQ:DRUG) Announces Earnings Results, Beats Estimates By $0.24 EPS - MarketBeat

Feb 14, 2025
pulisher
Feb 14, 2025

Bright Minds Biosciences Dramatic Surge Highlights the High-Stakes Nature of Biotech Investments - HPBL

Feb 14, 2025
pulisher
Feb 14, 2025

BriaCell Therapeutics: A Biotech Stock on the Brink of a Turnaround? - HPBL

Feb 14, 2025
pulisher
Feb 14, 2025

Biotechs on the Brink: 2 Stocks With Huge Potential - Benzinga

Feb 14, 2025
pulisher
Feb 14, 2025

Bright Minds Biosciences Shows Financial Improvement in Latest Report - TipRanks

Feb 14, 2025
pulisher
Feb 12, 2025

When (DRUG) Moves Investors should Listen - Stock Traders Daily

Feb 12, 2025
pulisher
Feb 05, 2025

SEC Form F-3 filed by Bright Minds Biosciences Inc. - Quantisnow

Feb 05, 2025
pulisher
Feb 04, 2025

More Money In The Bank For Bright Minds Biosciences Insiders Who Divested CA$16m - Simply Wall St

Feb 04, 2025
pulisher
Feb 04, 2025

How To Buy Bright Minds Biosciences Inc. Stock Online in February 2025 - Traders Union

Feb 04, 2025
pulisher
Jan 31, 2025

Long Term Trading Analysis for (DRUG) - Stock Traders Daily

Jan 31, 2025
pulisher
Jan 26, 2025

Bright Minds Biosciences: Looking To Change Scope Of Epilepsy Disorder Treatments With BMB-101 - Seeking Alpha

Jan 26, 2025
pulisher
Jan 26, 2025

Bright Minds Biosciences (NASDAQ:DRUG) Research Coverage Started at Piper Sandler - Defense World

Jan 26, 2025
pulisher
Jan 24, 2025

Piper Sandler sets $93 target for Bright Minds Biosciences stock - MSN

Jan 24, 2025
pulisher
Jan 24, 2025

Piper Sandler Initiates Coverage of Bright Minds Biosciences (DRUG) with Overweight Recommendation - MSN

Jan 24, 2025
pulisher
Jan 24, 2025

Piper Sandler sets $93 target for Bright Minds Biosciences stock By Investing.com - Investing.com South Africa

Jan 24, 2025
pulisher
Jan 24, 2025

Cantor Fitzgerald Predicts DRUG FY2025 Earnings - Defense World

Jan 24, 2025
pulisher
Jan 23, 2025

Cantor Fitzgerald Comments on DRUG FY2025 Earnings - MarketBeat

Jan 23, 2025
pulisher
Jan 23, 2025

Bright Minds Biosciences (NASDAQ:DRUG) Now Covered by Analysts at Piper Sandler - MarketBeat

Jan 23, 2025
pulisher
Jan 23, 2025

This Prudential Financial Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Thursday - Benzinga

Jan 23, 2025
pulisher
Jan 22, 2025

5-HT2 Agonist Clinical Trial Pipeline Appears Robust With - GlobeNewswire

Jan 22, 2025
pulisher
Jan 21, 2025

Learn to Evaluate (DRUG) using the Charts - Stock Traders Daily

Jan 21, 2025
pulisher
Jan 16, 2025

Bright Minds Biosciences Appoints New Chief Medical Officer to Advance CNS Therapeutics - MSN

Jan 16, 2025
pulisher
Jan 14, 2025

Top 4 Canadian Biotech Stocks (Updated January 2025) - Investing News Network

Jan 14, 2025
pulisher
Jan 14, 2025

Head-To-Head Analysis: Bright Minds Biosciences (NASDAQ:DRUG) versus Enlivex Therapeutics (NASDAQ:ENLV) - Defense World

Jan 14, 2025
pulisher
Jan 12, 2025

Cantor Fitzgerald Begins Coverage on Bright Minds Biosciences (NASDAQ:DRUG) - Defense World

Jan 12, 2025
pulisher
Jan 12, 2025

HC Wainwright Begins Coverage on Bright Minds Biosciences (NASDAQ:DRUG) - Defense World

Jan 12, 2025
pulisher
Jan 10, 2025

Bright Minds Biosciences (NASDAQ:DRUG) Coverage Initiated by Analysts at Cantor Fitzgerald - MarketBeat

Jan 10, 2025
pulisher
Jan 10, 2025

Bright Minds Biosciences (NASDAQ:DRUG) Earns Buy Rating from Analysts at HC Wainwright - MarketBeat

Jan 10, 2025
pulisher
Jan 10, 2025

Cantor Fitzgerald Initiates Coverage of Bright Minds Biosciences (DRUG) with Overweight Recommendation - MSN

Jan 10, 2025
pulisher
Jan 08, 2025

Top 5 Small-cap Biotech Stocks (Updated January 2025) - Nasdaq

Jan 08, 2025
pulisher
Jan 07, 2025

Bright Minds Biosciences Appoints Pharmaceutical Leader, Stephen Collins, M.D., Ph.D., as Chief Medical Officer - The Manila Times

Jan 07, 2025

Bright Minds Biosciences Inc (DRUG) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Bright Minds Biosciences Inc 주식 (DRUG) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Cormorant Asset Management, LP
10% Owner
Oct 15 '24
Buy
5.53
372,591
2,061,574
825,000
Cormorant Asset Management, LP
10% Owner
Oct 16 '24
Buy
23.46
50,000
1,172,813
875,000
$60.58
price down icon 3.01%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
자본화:     |  볼륨(24시간):